Screening for Latent Infections Among Users of High-Risk Immunosuppressants: A Cross-Sectional Analysis From the Veterans Health Administration Healthcare System.
Gabriela SchmajukAnna D WareGary TarasovskyJing LiRonald George HauserKarine Rozenberg-Ben-DrorMary A WhooleyPublished in: Journal of patient safety (2022)
Approximately two-thirds of veterans taking b/ts DMARDs have received guideline-recommended screening for HBV, HCV, and TB, but substantial facility variation was observed. Performance measures, robust multidisciplinary workflows, and electronic health record-based tools to feed information back to providers may improve screening rates for low-performing facilities.